Premium
Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party
Author(s) -
Marsh Judith,
Socie Gerard,
Tichelli Andre,
Schrezenmeier Hubert,
Hochsmann Britta,
Risitano Antonio M.,
Fuehrer Monika,
Bekassy Albert N.,
Korthof Elizabeth T.,
Locasciulli Anna,
Ljungman Per,
Bacigalupo Andrea,
Camitta Bruce,
Young Neal S.,
Passweg Jakob
Publication year - 2010
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2010.08200.x
Subject(s) - medicine , alemtuzumab , hematology , aplastic anemia , transplantation , lymphoma , immunology , bone marrow